372 related articles for article (PubMed ID: 33423943)
1. A Systematic Review of Focal Ablative Therapy for Clinically Localised Prostate Cancer in Comparison with Standard Management Options: Limitations of the Available Evidence and Recommendations for Clinical Practice and Further Research.
Bates AS; Ayers J; Kostakopoulos N; Lumsden T; Schoots IG; Willemse PM; Yuan Y; van den Bergh RCN; Grummet JP; van der Poel HG; Rouvière O; Moris L; Cumberbatch MG; Lardas M; Liew M; Van den Broeck T; Gandaglia G; Fossati N; Briers E; De Santis M; Fanti S; Gillessen S; Oprea-Lager DE; Ploussard G; Henry AM; Tilki D; van der Kwast TH; Wiegel T; N'Dow J; Mason MD; Cornford P; Mottet N; Lam TBL
Eur Urol Oncol; 2021 Jun; 4(3):405-423. PubMed ID: 33423943
[TBL] [Abstract][Full Text] [Related]
2. Ablative therapy for people with localised prostate cancer: a systematic review and economic evaluation.
Ramsay CR; Adewuyi TE; Gray J; Hislop J; Shirley MD; Jayakody S; MacLennan G; Fraser C; MacLennan S; Brazzelli M; N'Dow J; Pickard R; Robertson C; Rothnie K; Rushton SP; Vale L; Lam TB
Health Technol Assess; 2015 Jul; 19(49):1-490. PubMed ID: 26140518
[TBL] [Abstract][Full Text] [Related]
3. Benefits and Risks of Primary Treatments for High-risk Localized and Locally Advanced Prostate Cancer: An International Multidisciplinary Systematic Review.
Moris L; Cumberbatch MG; Van den Broeck T; Gandaglia G; Fossati N; Kelly B; Pal R; Briers E; Cornford P; De Santis M; Fanti S; Gillessen S; Grummet JP; Henry AM; Lam TBL; Lardas M; Liew M; Mason MD; Omar MI; Rouvière O; Schoots IG; Tilki D; van den Bergh RCN; van Der Kwast TH; van Der Poel HG; Willemse PM; Yuan CY; Konety B; Dorff T; Jain S; Mottet N; Wiegel T
Eur Urol; 2020 May; 77(5):614-627. PubMed ID: 32146018
[TBL] [Abstract][Full Text] [Related]
4. Quality of Life Outcomes after Primary Treatment for Clinically Localised Prostate Cancer: A Systematic Review.
Lardas M; Liew M; van den Bergh RC; De Santis M; Bellmunt J; Van den Broeck T; Cornford P; Cumberbatch MG; Fossati N; Gross T; Henry AM; Bolla M; Briers E; Joniau S; Lam TB; Mason MD; Mottet N; van der Poel HG; Rouvière O; Schoots IG; Wiegel T; Willemse PM; Yuan CY; Bourke L
Eur Urol; 2017 Dec; 72(6):869-885. PubMed ID: 28757301
[TBL] [Abstract][Full Text] [Related]
5. Radical prostatectomy versus deferred treatment for localised prostate cancer.
Vernooij RW; Lancee M; Cleves A; Dahm P; Bangma CH; Aben KK
Cochrane Database Syst Rev; 2020 Jun; 6(6):CD006590. PubMed ID: 32495338
[TBL] [Abstract][Full Text] [Related]
6. An Updated Systematic Review on Focal Therapy in Localized Prostate Cancer: What Has Changed over the Past 5 Years?
Hopstaken JS; Bomers JGR; Sedelaar MJP; Valerio M; Fütterer JJ; Rovers MM
Eur Urol; 2022 Jan; 81(1):5-33. PubMed ID: 34489140
[TBL] [Abstract][Full Text] [Related]
7. Systematic review and economic modelling of the relative clinical benefit and cost-effectiveness of laparoscopic surgery and robotic surgery for removal of the prostate in men with localised prostate cancer.
Ramsay C; Pickard R; Robertson C; Close A; Vale L; Armstrong N; Barocas DA; Eden CG; Fraser C; Gurung T; Jenkinson D; Jia X; Lam TB; Mowatt G; Neal DE; Robinson MC; Royle J; Rushton SP; Sharma P; Shirley MD; Soomro N
Health Technol Assess; 2012; 16(41):1-313. PubMed ID: 23127367
[TBL] [Abstract][Full Text] [Related]
8. Salvage Local Treatments After Focal Therapy for Prostate Cancer.
Marra G; Valerio M; Emberton M; Heidenreich A; Crook JM; Bossi A; Pisters LL
Eur Urol Oncol; 2019 Sep; 2(5):526-538. PubMed ID: 31412013
[TBL] [Abstract][Full Text] [Related]
9. A systematic review of randomised controlled trials of radiotherapy for localised prostate cancer.
Wolff RF; Ryder S; Bossi A; Briganti A; Crook J; Henry A; Karnes J; Potters L; de Reijke T; Stone N; Burckhardt M; Duffy S; Worthy G; Kleijnen J
Eur J Cancer; 2015 Nov; 51(16):2345-67. PubMed ID: 26254809
[TBL] [Abstract][Full Text] [Related]
10. Primary Whole-gland Ablation for the Treatment of Clinically Localized Prostate Cancer: A Focal Therapy Society Best Practice Statement.
Deivasigamani S; Kotamarti S; Rastinehad AR; Salas RS; de la Rosette JJMCH; Lepor H; Pinto P; Ahmed HU; Gill I; Klotz L; Taneja SS; Emberton M; Lawrentschuk N; Wysock J; Feller JF; Crouzet S; Kumar M P; Seguier D; Adams ES; Michael Z; Abreu A; Jack Tay K; Ward JF; Shinohara K; Katz AE; Villers A; Chin JL; Stricker PD; Baco E; Macek P; Ahmad AE; Chiu PKF; Crawford ED; Rogers CG; Futterer JJ; Rais-Bahrami S; Robertson CN; Hadaschik B; Marra G; Valerio M; Chong KT; Kasivisvanathan V; Tan WP; Lomas D; Walz J; Guimaraes GC; Mertziotis NI; Becher E; Finelli A; Kasraeian A; Lebastchi AH; Vora A; Rosen MA; Bakir B; Arcot R; Yee S; Netsch C; Meng X; de Reijke TM; Tan YG; Regusci S; Benjamin TGR; Olivares R; Noureldin M; Bianco FJ; Sivaraman A; Kim FJ; Given RW; Dason S; Sheetz TJ; Shoji S; Schulman A; Royce P; Shah TT; Scionti S; Salomon G; Laguna P; Tourinho-Barbosa R; Aminsharifi A; Cathelineau X; Gontero P; Stabile A; Grummet J; Ledbetter L; Graton M; Stephen Jones J; Polascik TJ;
Eur Urol; 2023 Dec; 84(6):547-560. PubMed ID: 37419773
[TBL] [Abstract][Full Text] [Related]
11. Partial ablation versus radical prostatectomy in intermediate-risk prostate cancer: the PART feasibility RCT.
Hamdy FC; Elliott D; le Conte S; Davies LC; Burns RM; Thomson C; Gray R; Wolstenholme J; Donovan JL; Fitzpatrick R; Verrill C; Gleeson F; Singh S; Rosario D; Catto JW; Brewster S; Dudderidge T; Hindley R; Emara A; Sooriakumaran P; Ahmed HU; Leslie TA
Health Technol Assess; 2018 Sep; 22(52):1-96. PubMed ID: 30264692
[TBL] [Abstract][Full Text] [Related]
12. A Systematic Review of the Impact of Surgeon and Hospital Caseload Volume on Oncological and Nononcological Outcomes After Radical Prostatectomy for Nonmetastatic Prostate Cancer.
Van den Broeck T; Oprea-Lager D; Moris L; Kailavasan M; Briers E; Cornford P; De Santis M; Gandaglia G; Gillessen Sommer S; Grummet JP; Grivas N; Lam TBL; Lardas M; Liew M; Mason M; O'Hanlon S; Pecanka J; Ploussard G; Rouviere O; Schoots IG; Tilki D; van den Bergh RCN; van der Poel H; Wiegel T; Willemse PP; Yuan CY; Mottet N
Eur Urol; 2021 Nov; 80(5):531-545. PubMed ID: 33962808
[TBL] [Abstract][Full Text] [Related]
13. Oncological results and cancer control definition in focal therapy for Prostate Cancer: a systematic review.
Nicoletti R; Alberti A; Castellani D; Yee CH; Zhang K; Poon DMC; Chiu PK; Campi R; Resta GR; Dibilio E; Pirola GM; Chiacchio G; Fuligni D; Brocca C; Giulioni C; De Stefano V; Serni S; Gauhar V; Ng CF; Gacci M; Teoh JYC
Prostate Cancer Prostatic Dis; 2023 Jul; ():. PubMed ID: 37507479
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of Oncological Outcomes and Data Quality in Studies Assessing Nerve-sparing Versus Non-Nerve-sparing Radical Prostatectomy in Nonmetastatic Prostate Cancer: A Systematic Review.
Moris L; Gandaglia G; Vilaseca A; Van den Broeck T; Briers E; De Santis M; Gillessen S; Grivas N; O'Hanlon S; Henry A; Lam TB; Lardas M; Mason M; Oprea-Lager D; Ploussard G; Rouviere O; Schoots IG; van der Poel H; Wiegel T; Willemse PP; Yuan CY; Grummet JP; Tilki D; van den Bergh RCN; Cornford P; Mottet N
Eur Urol Focus; 2022 May; 8(3):690-700. PubMed ID: 34147405
[TBL] [Abstract][Full Text] [Related]
15. Robotic-assisted minimally invasive surgery for gynecologic and urologic oncology: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2010; 10(27):1-118. PubMed ID: 23074405
[TBL] [Abstract][Full Text] [Related]
16. Vascular-targeted Photodynamic Therapy in Unilateral Low-risk Prostate Cancer in Germany: 2-yr Single-centre Experience in a Real-world Setting Compared with Radical Prostatectomy.
Flegar L; Buerk B; Proschmann R; Propping S; Groeben C; Baunacke M; Herout R; Huber J; Thomas C; Borkowetz A
Eur Urol Focus; 2022 Jan; 8(1):121-127. PubMed ID: 33602642
[TBL] [Abstract][Full Text] [Related]
17. Focal therapy versus radical prostatectomy and external beam radiotherapy as primary treatment options for non-metastatic prostate cancer: results of a cost-effectiveness analysis.
Reddy D; van Son M; Peters M; Bertoncelli Tanaka M; Dudderidge T; Cullen E; Ho CLT; Hindley RG; Emara A; McCracken S; Orczyk C; Shergill I; Mangar S; Nigam R; Virdi J; Moore CM; Arya M; Shah TT; Winkler M; Emberton M; Falconer A; Belsey J; Ahmed HU
J Med Econ; 2023; 26(1):1099-1107. PubMed ID: 37656223
[TBL] [Abstract][Full Text] [Related]
18. The Benefits and Harms of Different Extents of Lymph Node Dissection During Radical Prostatectomy for Prostate Cancer: A Systematic Review.
Fossati N; Willemse PM; Van den Broeck T; van den Bergh RCN; Yuan CY; Briers E; Bellmunt J; Bolla M; Cornford P; De Santis M; MacPepple E; Henry AM; Mason MD; Matveev VB; van der Poel HG; van der Kwast TH; Rouvière O; Schoots IG; Wiegel T; Lam TB; Mottet N; Joniau S
Eur Urol; 2017 Jul; 72(1):84-109. PubMed ID: 28126351
[TBL] [Abstract][Full Text] [Related]
19. External Beam Radiotherapy Increases the Risk of Bladder Cancer When Compared with Radical Prostatectomy in Patients Affected by Prostate Cancer: A Population-based Analysis.
Moschini M; Zaffuto E; Karakiewicz PI; Andrea DD; Foerster B; Abufaraj M; Soria F; Mattei A; Montorsi F; Briganti A; Shariat SF
Eur Urol; 2019 Feb; 75(2):319-328. PubMed ID: 30293908
[TBL] [Abstract][Full Text] [Related]
20. Laparoscopic and robotic-assisted versus open radical prostatectomy for the treatment of localised prostate cancer.
Ilic D; Evans SM; Allan CA; Jung JH; Murphy D; Frydenberg M
Cochrane Database Syst Rev; 2017 Sep; 9(9):CD009625. PubMed ID: 28895658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
